rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
16
|
pubmed:dateCreated |
1999-10-27
|
pubmed:abstractText |
Intrauterine growth retardation (IUGR) is considered to be responsible for approximately 20% of short stature in adulthood. Although GH secretion is normal in the majority of cases, excellent results have been published by some authors using GH to treat children with height deficiency due to IUGR.
|
pubmed:language |
spa
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0025-7753
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
112
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
601-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10374174-Age Determination by Skeleton,
pubmed-meshheading:10374174-Body Constitution,
pubmed-meshheading:10374174-Body Weight,
pubmed-meshheading:10374174-Child,
pubmed-meshheading:10374174-Child, Preschool,
pubmed-meshheading:10374174-Female,
pubmed-meshheading:10374174-Fetal Growth Retardation,
pubmed-meshheading:10374174-Growth Disorders,
pubmed-meshheading:10374174-Growth Hormone,
pubmed-meshheading:10374174-Hemoglobins,
pubmed-meshheading:10374174-Humans,
pubmed-meshheading:10374174-Insulin-Like Growth Factor Binding Proteins,
pubmed-meshheading:10374174-Insulin-Like Growth Factor I,
pubmed-meshheading:10374174-Male,
pubmed-meshheading:10374174-Thyroxine
|
pubmed:year |
1999
|
pubmed:articleTitle |
[The effectiveness of recombinant growth hormone in height deficiency due to intrauterine growth retardation].
|
pubmed:affiliation |
Hospital Universitario Materno-Infantil Vall d'Hebron, Barcelona.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|